Literature DB >> 2026171

Mapping the functional domains of the eukaryotic elongation factor 1 beta gamma.

H van Damme1, R Amons, G Janssen, W Möller.   

Abstract

The functional domains of the eukaryotic elongation factor (EF) 1 beta gamma have been delineated with the use of limited proteolysis, protein microsequencing, gel electrophoresis under non-denaturing conditions and antibodies against EF-1 beta and EF-1 gamma. By means of limited proteolysis, it was possible to obtain large fragments of EF-1 beta. In contrast to amino-terminal fragments, those derived from the carboxy-terminal part of EF-1 beta were still active in enhancing the guanine nucleotide exchange of GDP bound to EF-1 alpha. With the same technique of limited proteolysis, it was possible to isolate a trypsin-resistant core from EF-1 beta gamma containing polypeptide chain fragments derived from both subunits. A polyvalent antiserum against EF-1 beta and two monoclonal antibodies against EF-1 gamma were used to identify the protein fragments in this core. The monoclonal antibodies were shown to recognize different epitopes, one localized on the amino-terminal and another on the carboxy-terminal half of EF-1 gamma. The antiserum against EF-1 beta and one of the monoclonal antibodies (mAb 36E5), which recognized the amino-terminal half of EF-1 gamma, reacted with this trypsin-resistant core. We conclude that the amino-terminal halves of both EF-1 beta and EF-1 gamma are firmly attached to each other, and that the carboxy-terminal part of EF-1 beta interacts with EF-1 alpha.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026171     DOI: 10.1111/j.1432-1033.1991.tb15938.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  A structural model for elongation factor 1 (EF-1) and phosphorylation by protein kinase CKII.

Authors:  G T Sheu; J A Traugh
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Nucleotide sequence of a rabbit cDNA encoding elongation factor 1 gamma.

Authors:  G T Sheu; J A Traugh
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

3.  The C-terminal region of human eukaryotic elongation factor 1Bδ.

Authors:  Huiwen Wu; Chen Wang; Weibin Gong; Jinfeng Wang; Jinsong Xuan; Sarah Perrett; Yingang Feng
Journal:  J Biomol NMR       Date:  2016-01-13       Impact factor: 2.835

Review 4.  The plant translational apparatus.

Authors:  K S Browning
Journal:  Plant Mol Biol       Date:  1996-10       Impact factor: 4.076

5.  eIF2B, the guanine nucleotide-exchange factor for eukaryotic initiation factor 2. Sequence conservation between the alpha, beta and delta subunits of eIF2B from mammals and yeast.

Authors:  N T Price; H Mellor; B L Craddock; K M Flowers; S R Kimball; T Wilmer; L S Jefferson; C G Proud
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

6.  Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex.

Authors:  G Palacios; T I Shaw; Y Li; R K Singh; M Valentine; J T Sandlund; M S Lim; C G Mullighan; V Leventaki
Journal:  Leukemia       Date:  2016-11-14       Impact factor: 11.528

Review 7.  Peptide-chain elongation in eukaryotes.

Authors:  C G Proud
Journal:  Mol Biol Rep       Date:  1994-05       Impact factor: 2.316

8.  Mapping the human translation elongation factor eEF1H complex using the yeast two-hybrid system.

Authors:  Francisco Mansilla; Irene Friis; Mandana Jadidi; Karen M Nielsen; Brian F C Clark; Charlotte R Knudsen
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

9.  Mutations in elongation factor 1beta, a guanine nucleotide exchange factor, enhance translational fidelity.

Authors:  A Carr-Schmid; L Valente; V I Loik; T Williams; L M Starita; T G Kinzy
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

10.  Characterisation of translation elongation factor eEF1B subunit expression in mammalian cells and tissues and co-localisation with eEF1A2.

Authors:  Yuan Cao; Miriam Portela; Justyna Janikiewicz; Jennifer Doig; Catherine M Abbott
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.